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In Brief
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of domains with distinct methylation
endpoints and reveals that antagonisms
between histone methylations enhance
the stability of epigenetic states.
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https://doi.org/10.1016/j.celrep.2019.12.060SUMMARY
Chromatin statesmust bemaintained during cell pro-
liferation to uphold cellular identity and genome
integrity. Inheritance of histone modifications is cen-
tral in this process. However, the histone modifica-
tion landscape is challenged by incorporation of
new unmodified histones during each cell cycle,
and the principles governing heritability remain
unclear. We take a quantitative computational
modeling approach to describe propagation of his-
tone H3K27 and H3K36 methylation states. We mea-
sure combinatorial H3K27 and H3K36 methylation
patterns by quantitative mass spectrometry on sub-
sequent generations of histones. Using model com-
parison, we reject active global demethylation and
invoke the existence of domains defined by distinct
methylation endpoints. We find that H3K27me3 on
pre-existing histones stimulates the rate of de novo
H3K27me3 establishment, supporting a read-write
mechanism in timely chromatin restoration. Finally,
we provide a detailed quantitative picture of the
mutual antagonism between H3K27 and H3K36
methylation and propose that it stabilizes epigenetic
states across cell division.
INTRODUCTION
Most cells in a multicellular organism can be functionally very
distinct despite the fact that they share the same genomicCell Re
This is an open access article under the CC BY-Ninformation. Cellular specialization during development is based
on the ability to establish, maintain, and execute different gene
expression programs. How transcriptional programs are
established during development and maintained in cycling cells
is a fundamental question in biology. Chromatin organization
plays a fundamental role in this process, but it remains unclear
how specific chromatin states are stably inherited from a mother
cell to its daughters. Histone post-translational modifications are
highly cell-type specific and constitute an important level of
chromatin regulation that controls transcription programs.
Histonemodifications can be inherited frommother cells through
DNA replication and mitosis to daughter cells, but the mecha-
nisms underlying this inheritance are still not fully understood.
During DNA replication, old histones H3-H4 are evicted from
the parental strand and re-deposited onto the two daughter
DNA strands. Histone acetylation and methylation marks are
maintained on the old histones during this recycling process
(Alabert et al., 2015; Scharf et al., 2009; Xu et al., 2012).
Recycling is accurate and almost symmetric, such that posi-
tional information is maintained and the two strands receive
close-to-equal contributions of old modified histones (Petryk
et al., 2018; Reveron-Gomez et al., 2018; Yu et al., 2018). In
parallel, newly synthesized histones are deposited to maintain
nucleosome density. Because new histones are largely unmod-
ified, except from transient di-acetylation on histone H4, histone
methylation levels are diluted 2-fold on the daughter strands as
compared to parental chromatin. To maintain chromatin states
across cell division, new histones become modified to resemble
their neighboring old histones. This process of chromatin
restoration is highly heterogeneous, taking place across the full
cell cycle with modification and locus-specific kinetics (Alabert
et al., 2015; Reveron-Gomez et al., 2018).ports 30, 1223–1234, January 28, 2020 ª 2020 The Authors. 1223
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Despite major advances in understanding histone dynamics
coupled to DNA replication, the picture remains rudimentary
with respect to the mechanisms that govern restoration and
thus heritability of modifications. This partly reflects the
complexity in the regulation of histone modifications, involving
positive and negative cross-talk among modifications them-
selves and with other chromatin features (e.g., DNA methylation
and sequence elements) and processes (e.g., transcription).
A favored paradigm for inheritance of the repressive modifica-
tions, H3K9me3 and H3K27me3, is self-propagation through a
read-write mechanism where the enzymes are activated by the
presence of the modification on nearby nucleosomes (Reinberg
and Vales, 2018). Structural and biochemical evidence strongly
support a read-write mechanism in H3K9me3 and H3K27me3
establishment and spreading (Allshire and Madhani, 2018; Rein-
berg and Vales, 2018): enhancer of zeste homolog 2 (EZH2), the
catalytic subunit of polycomb repressive complex 2 (PRC2) that
mediates mono-, di-, and tri-methylation of H3K27 (from here on
denoted as K27me1/2/3) is allosterically activated by binding
of pre-existing K27me3 to an aromatic cage in the embryonic
ectoderm development (EED) subunit (Reinberg and Vales,
2018). This can work in trans between neighboring nucleosomes
(Poepsel et al., 2018) and could allow K27me3 on recycled old
histones to instruct establishment of K27me3 on new histones
after DNA replication (Reinberg and Vales, 2018). Consistent
with this, EED cage mutations that abrogate allosteric activation
reduce K27me3 levels and spreading (Lee et al., 2018; Oksuz
et al., 2018). Intriguingly, PRC2 also methylates its binding part-
ner JARID2 on a K27 mimicking peptide that also can activate
the enzyme allosterically (Sanulli et al., 2015). However, other
factors including genomic features, RNA and H2A K119 ubiquiti-
nation by polycomb repressive complex 1 (PRC1), can also
contribute to PRC2 recruitment and deposition of H3K27me3
(Blackledge et al., 2014; Cooper et al., 2014; King et al., 2018;
Laugesen et al., 2019; Yu et al., 2019). In Drosophila, self-prop-
agation is not sufficient for K27me3 maintenance as sequence
elements directing PRC1/2 recruitment are also required (Cole-
man and Struhl, 2017; Laprell et al., 2017). In mammalian cells,
CpG richness is important for PRC2 recruitment, but a distinct
recognition element remains to be identified (Laugesen et al.,
2019). However, reintroduction of PRC2 into embryonic stem
cells (ESCs) devoid of K27 methylation fully restores the
K27me3 landscape (Højfeldt et al., 2018; Oksuz et al., 2018).
This argues against a critical role for allosteric activation in estab-
lishment, but its importance in K27me3 maintenance remains
debated.
K27me shows an intriguing interplay with methylation of K36,
located in close vicinity on the H3 tail. H3K36 mono-, di-, and tri-
methylation (from here on called K36me1/2/3) occupy distinct
regions of the genome, much like K27me1/2/3, but is linked to
transcription rather than repression. K36me2 is imposed by
NSD1-3 and ASH1/1L and broadly distributed across the
genome, including genic and intergenic regions. K36me3 is
imposed by a single enzyme, SETD2, over gene bodies and
promotes transcription fidelity by restoring a non-permissive
chromatin state following RNA Pol II passage (Huang and Zhu,
2018). Consistent with their opposite roles in transcription,
K36me3 and K27me3 are mutually exclusively distributed along1224 Cell Reports 30, 1223–1234, January 28, 2020chromosomes (Ernst and Kellis, 2010; Streubel et al., 2018).
Intriguingly, deregulation of these modifications can give rise to
similar clinical outcomes, as Weaver syndromes (missense
mutations in PRC2 subunits) and Sotos syndromes (loss-of-
function mutations or deletions in NSD1 or SETD2) largely
phenocopy each other (Tatton-Brown and Rahman, 2013).
Both K27 and K36 are also the target of recurrent mutations in
histone genes, leading to expression of so-called oncohistones
(K27M and K36M), which are drivers of distinct types of pediatric
cancers (Mohammad and Helin, 2017). Notably, K36 and K27
methylation landscapes are highly interdependent: when one
modification is impaired, the other one increases and spreads
(Lu et al., 2016; Oksuz et al., 2018; Stafford et al., 2018; Streubel
et al., 2018). Consistent with this, a bi-directional antagonism
was predicted based on computational modeling of in vivo K27
and K36methylation dynamics measured bymass spectrometry
in cancer cells (Zheng et al., 2012). Biochemical analysis showed
that K36me2/3 directly blocked PRC2-mediated K27me2/3 on
the same histone tail (Schmitges et al., 2011; Yuan et al.,
2011), and deposition of K36me2 was proposed to directly limit
K27me3 spreading (Streubel et al., 2018). Yet, genome-wide
analysis showed substantial overlap between K27me2 and
K36me2 and a moderate correlation between K27me3 and
K36me2 (Streubel et al., 2018). Also, it remains unclear how
K27me2/3 might counteract K36me2/3. Thus, the nature of the
antagonistic relationship and how they may influence each other
during maintenance and establishment remains puzzling.
In this study we take a quantitative approach to understand
how histone modifications are inherited across cell division,
monitoring in vivo dynamics of the tightly linked histone modifi-
cations K36me and K27me. We analyzed 15 distinct K27 and
K36 methylation states on three different generations of
histones. Using a mechanistic model for histone methylation,
parameter inference, and quantitative hypothesis testing,
we found that domains with distinct end-point methylation states
had to be introduced to fit our data. We provide a detailed, quan-
titative picture of the K27me/K36me antagonistic relationship
and reveal that co-occupancy of these modifications can be
explained by their distinct establishment kinetics. We also
demonstrate, using an EZH2 inhibitor, that the rate of de novo
K27me3 on newly deposited histones is enhanced by pre-exist-
ing K27me3, lending strong support to the read-write model.
RESULTS
Slow K27me3 Establishment in Mouse ESCs (mESCs)
To identify the principles for howK27me and K36me patterns are
propagated in mESCs, we chose a quantitative approach to
measure how methylations developed over time on subsequent
generations of histones (Figure 1A).We used triple stable isotope
labeling by amino acids in cell culture (SILAC) with light (R0K0),
medium (R6K4), and heavy (R10K8) amino acids to quantitate
methylation patterns over time (Figures 1B and S1A). This
scheme allowed us to measure methylation levels as they devel-
oped over time on pre-existing histones (generation 1), new his-
tones incorporated in a narrow time window and allowed to age
(generation 2), and new histones continuously incorporated over
time to reach steady-state levels (generation 3) (Figure 1B).
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Figure 1. Propagation Dynamics of K27 and K36 Methylation in
mESCs
(A) Strategy to analyze three successive histone generations by triple
SILAC.
(B) Experimental design of pulse chase SILAC labeling in asynchronous
mESCs.
(C) Heatmap showing the distribution of K27 and K36 methylation states
in steady state prior to labeling. The sum of each methylation is shown on
the right for K27 and at the bottom for K36.
(D) Methylation levels on generation 2 histones for K27 and K36. me1,
mono-methyl; me2, di-methyl; me3, tri-methyl. Data are shown as
mean ± SD, nR 6.
(E) Methylation levels on generation 3 histones for K27 and K36. Data are
shown as mean ± SD, nR 6.
(F) Methylation levels on generation 1 histones for K27 and K36. Data are
shown as mean ± SD, nR 6.
See also Figure S1.
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Before switching culture medium (Figure 1B, t = 3 h), genera-
tion 1 histones constituted the total pool of nucleosomal histones
and thus provided the total methylation level at steady state,
including fully modified histones and histones that still under-
went modification. We focused our analysis on combinatorial
K27 and K36methylation patterns and, for comparison, included
analysis of H3K9 and H4K20 methylation. In steady state, the
most abundant modification was K27me2 present on 34% ±
5% (mean ± SD, n = 6 experiments) of histone H3, while
20% ± 2% carried K27me1 and 21% ± 1% carried K27me3 (Fig-
ures 1C and S1B). About 50% of histones carried K36 methyl-
ation with K36me1 on 20% ± 4%, K36me2 on 12% ± 2%, and
K36me3 on 14% ± 4%. This is overall in good accordance with
previous mass spectrometry analysis of H3 methylation in
mESCs growing in 2i medium (Lee et al., 2018; Oksuz et al.,
2018).
We took advantage of the triple SILAC set-up to determine
how K27 methylation is established on newly synthesized
histones in generation 2. We observed a stepwise acquisition
of K27 methylation (Figures 1D and S1C). K27me1 occurred
almost concomitant with histone incorporation and reached its
maximum at the 0-hour time point. This was followed by a surge
of K27me2 within the first 3 h and a peak 8 h after incorporation.
K27me3 establishment occurred with a substantial delay and
continued to rise for more than 16 h after incorporation (Fig-
ure 1D). Consistent with the latter, the analysis of generation 1
histones demonstrated that old histones continued to gain
K27me3 and progressed toward a higher methylation state (Fig-
ure 1E). As expected, generation 3 histones followed a trajectory
toward the steady-state levels (Figure 1F), reaching methylation
levels comparable to those of generation 1 at the beginning of
the experiment (Figure S1B). Collectively, this mirrors the pattern
of K27 methylation establishment in HeLa cells (Alabert et al.,
2015), although the kinetics are faster in mESCs, matching their
short cell cycle of around 15 h (Figure S1A). The continuous
methylation on old histones is specific to K27, as neither
K36me3 nor H3K9me3 continues to rise on old histones beyond
one cell cycle (Figures 1F and S1E). This may reflect an inherent
feature of the EZH2 enzyme that has a slow methylation rate for
K27me2 to K27me3 (Justin et al., 2016; McCabe et al., 2012) and
that the enzyme is challenged by the large substrate pool (in
steady-state almost 75% of nucleosomal histones carry either
K27me1/2/3) (Figures 1F and S1B). mESCs contain high concen-
tration of PRC2 (Stafford et al., 2018) probably explaining how
theymaintain high levels of K27me3 level through rounds of rapid
cell divisions despite slow K27 tri-methylation establishment
(Figure S1B).
K36me1/2/3 establishment was continuous and slow, lasting
from the time of incorporation up to 16 h, with K36me1 initiating
shortly after incorporation and K36me2/3 delayed for a couple of
hours (Figure 1D). K36me1 and K36me2 establishment were
both delayed compared to K27me1 and K27me2, respectively.
These kinetics largely agree with a previous study (Zheng
et al., 2012). We observed a similar acquisition pattern for
K9me1/2/3 (Figure S1E), while H4K20me1/2 showed stepwise
acquisition similar to K27me1/2/3 (Figure S1F). It is not clear
what governs this behavior, but it is notable that both K27me
and H4K20me are highly abundant marks in mESCs 2i and1226 Cell Reports 30, 1223–1234, January 28, 2020that K9me shows stepwise acquisition in HeLa cells, where
K9me2/3 levels are much higher than in mESCs 2i (Alabert
et al., 2015). Curiously, the K36me2 and K36me3 kinetics were
highly similar, suggesting that K36me2, mediated by NSD1-3
and ASH1 enzymes, might be rate limiting for K36me3 establish-
ment, mediated by SETD2. The division of labor between the
enzymes that carry out di- and tri-methylation may thus be an
obstacle for K36 tri-methylation.
Computational Model for Propagation of K27 and K36
Methylation
Our approach allowed us to measure all combinatorial methyl-
ation states of K27 and K36 (Figure 1C) apart from
K27me3K36me3, which was below our detection limit. To under-
stand the dynamics in the three histone generations, we
employed mechanistic modeling. Such a model can describe
the temporal evolution of the methylation levels. By fitting mech-
anistic models to our comprehensive data, we were able to
test hypotheses on global demethylation (Reveron-Gomez
et al., 2018; Zheng et al., 2012) and the previously reported nega-
tive interaction between methylations on the two residues
(Schmitges et al., 2011; Stafford et al., 2018; Voigt et al., 2012;
Yuan et al., 2011). For a mathematical description, we used a
system of ordinary differential equations and assumed that tran-
sitions betweenmodifications followedmass action kinetics (see
STAR Methods and Figures S2A and S2B for more details on
the modeling). Moreover, newly incorporated histones during
cell division were assumed to be unmodified on K27 and K36
(Alabert et al., 2015; Jasencakova et al., 2010; Loyola et al.,
2006). Based on these assumptions, we considered two different
model variants. In the ‘‘global model’’ (similar to the approach of
Zheng et al., 2012; see STAR Methods for a detailed description
and comparison), each state develops in time due to methylation
and demethylation (Figure 2A). Here, each histone tail has the
same rate to acquire or loose a methyl group, independent of
its genomic position. Since the existence of global demethylation
of histones has been questioned recently (Reveron-Gomez et al.,
2018), we tested whether the global model required demethyla-
tion. We found that this model was not able to fit the data without
accounting for demethylation (Figure 2C). Thus, we considered
an alternative model without demethylation. This ‘‘domain’’
model was motivated by the idea that the genomic context of
the histones might define its methylation state. It assumes that
histones in certain domains can only be methylated up to a
defined final state (Figure 2B). Domains may form due to con-
straints in the availability and activity of enzymes, reflecting
that they are recruited and activated at specific regions of the
genome (Ferrari et al., 2014; Lee et al., 2018) and lead to inhomo-
geneous distributions of enzymes in the nucleus. The domain to
which a histone belongs dictates the final methylation state, i.e.,
whether it can be further methylated or not. Fitting the models to
the data, we found that a domain model with 32 parameters and
no demethylation (Figure 2B; STAR Methods) could explain
modification dynamics in all generations similarly well as the
global model with 30 parameters and active demethylation (Fig-
ures 2C and S2C–S2E; STAR Methods).
To examine the existence of global demethylation as the test-
able difference of the two model hypotheses, we inhibited K27
A B
C
D
E
F
Figure 2. Computational Domain Model Predicts Dynamics during Inhibitor Treatment without Global Demethylation
(A) The global model describes the abundance of methylations on K27 and K36with methylation and demethylation. Differences between generations occur from
the incorporation of unmodified histones (dotted diagonal arrow): this only occurs for the time when the cells are in the corresponding culture medium.
(B) The domain model assumes that the histone tails are methylated until they reach a defined final state, which depends on the domain the histone belongs to. In
contrast to the global model, it requires no demethylation.
(C) Both the global and domain model can describe methylation dynamics of untreated cells in all three generations. Data are shown as mean ± SD, n = 9.
(D) Experimental design of EZH2 inhibitor treatment.
(E) Only the domain model prediction fits the K27me3 levels of generation 1 during inhibitor treatment. Data are shown as mean ± SD, n = 3.
(F) The model averaged fluxes for the population steady state show antagonism between K27 and K36methylation. The width of the black lines indicates the size
of the flux.
See also Figure S2.
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methylation with an EZH2 inhibitor (EPZ-6438) and measured the
histone modification dynamics over time (Figure 2D). K27me3
levels remained stable at around 20% for 16 h (Figure 2E). We
used this finding to test the two models. First, we estimate the ef-
ficiency of the EZH2 inhibitor from the ratio of K27me3 to K27me2
in untreated and treated cells to be around 92.8%± 5.2% (mean±
SD, n = 3 replicates; see Figures S2F andS2GandSTARMethods
for details). We then predicted K27me3 levels upon inhibitor treat-
ment for the twomodel hypotheses. The experimentally observed
stability of K27me3 in the presence of the inhibitor was inconsis-
tent with the global model that assumed demethylation, but it
could bewell explained quantitativelywith our domainmodel (Fig-
ure 2E). We thus rejected the global model and used the domain
model to analyze our data further. The global model relies on sub-
stantial demethylation, with the differential activity of demethy-
lases having to play a major role in establishing distinct methyl-
ated domains. In contrast, the domain model stresses the
importance of the environment where the histones are deposited,
with the differential activity of histone writers determining the final
state. We note that the latter is consistent with recent literature
showing that PRC2 accessory components, like JARID2 and
PCLs, promote occupancy in K27me3 domains (e.g., CpG
islands), while PRC2, devoid of such accessory factors, can
reside in other genomic locations and promote H3K27me1/2
(Healy et al., 2019; Hojfeldt et al., 2019; Schuettengruber et al.,
2017).
To interrogate interactions between the two residues, we
calculated the methylation flux in steady state, defined as the
product of the modification state abundance times the reaction
rate constant (STAR Methods). The fluxes from K27me0 to
K27me3 with no K36 methylation made up 57.4% of all fluxes
(Figure 2F). We found evidence for antagonistic behavior in
both directions. In all cases with fluxes over 0.5 h1, the addition
of a methyl mark to the site with the higher modified state was
more likely than modification of the less modified site (Figures
2F and S2H). For example, there is a 2.5/0.21 = 11.9-fold
increased probability for further methylation of K27 on a
histone already carrying K27me1K36me0 as compared to
methylation of K36 and a 0.67/0.15 = 4.5-fold increase for further
methylation of K36 on K27me0K36me2 as compared to adding
methylation to K27 (STAR Methods). In cases where the lysines
are equally methylated, K27 methylation is favored on naive
histones (K27me0K36me0) and on di-methylated histones
(K27me2K36me2), while K36 methylation is favored when both
residues are mono-methylated (K27me1K36me1). Collectively,
our modeling provides a detailed quantitative picture of the
antagonistic relationship between K27me and K36me. We previ-
ously proposed that an increased rate of cell division might lead
to loss of K27me3 by dilution (Alabert et al., 2015) due to the slow
rate of establishment on new histones.We tested this hypothesis
by increasing the proliferation rate in our model, and this re-
vealed that a shorter cell cycle (with all other parameters
unchanged) will indeed reduce the steady-state level of
K27me3 (Figure S2I). This is consistent with recent work showing
that mESCs have higher levels of K27me3 when grown in 2i me-
dium as compared to serum and leukemia inhibitory factor (LIF),
which speeds up the cell cycle substantially (van Mierlo et al.,
2019).1228 Cell Reports 30, 1223–1234, January 28, 2020Pre-existing K27me3 on Old Histones Increases the
Rate of De Novo K27me3
Based on the ability of K27me3 to allosterically activate PRC2, it
has been predicted that parental histones carrying K27me3
directly stimulate K27me3 establishment on newly incorporated
histones (Margueron et al., 2009; Sanulli et al., 2015). Our quanti-
tative system yielded the unique opportunity to test this hypothe-
sis by directly measuring the contribution of parental K27me3 to
K27me3 establishment on new histones (Figure 3A). To erase
K27me3 from parental histones, cells were treated for 7 days
with the EZH2 inhibitor (Figure 3B) (Højfeldt et al., 2018). After
inhibitor treatment, the level of K27me3 dropped below 3% and
K27me2 was also strongly reduced, while K27me1 accumulated
(Figure 3C). This is consistent with previous work (Højfeldt et al.,
2018) and suggests that, in this setting, EZH1, which is not
targeted by the inhibitor, catalyzes K27me1. Focusing on the
methylation kinetics on new histones (generation 2), we found
that the establishment of K27me2/3 methylation was delayed in
cells lacking K27me3 (Figure 3D). Establishment of other methyl-
ation marks, including H3K9me3 (Figure S3A), was not affected,
excluding unspecific effects on methylation dynamics. We
performed quantitative model selection to identify rate constants
that differ between generation 2 histones of untreated and recov-
ering cells (Figures 3E and S3B; STARMethods). We found that a
model with substantial differences in K27 mono-methylation of
K27me0K36me0, K27 tri-methylation of K27me2K36me0, and
K36 mono-methylation of K27me0K36me0 and K27me2K36me0
is able to explain the data and the differences between untreated
and recovering cells (Figures 3E and S3B). The reduced rate of
K27 mono-methylation of K27me0K36me0 and K27 tri-methyl-
ation of K27me2K36me0 strongly support the existence of a
feed-forward loop, whereby parental K27me3 stimulates estab-
lishment of K27 methylation on new histones by increasing the
enzymatic rate. The changes in K36 mono-methylation rates
were unexpected, showing both up and downregulation. In
particular, the 10-fold increased rate of K36 mono-methylation
on K27me2K36me0 is substantial and further highlights the close
interdependence of the K27 and K36 landscapes, as explored
below.
K36 Methylation Can Lock Cells in an Aberrant
Modification State
Cells fully restored K27me3 levels after removal of the inhibitor
within approximately five generations (Figure S3C), as reported
previously (Højfeldt et al., 2018). This relatively slow recovery
was unlikely to only reflect the delay in K27me2/3 on new
histones, manifested on a scale of hours rather than cell gener-
ations. We thus also analyzed the recovery of the old histones
(generation 1) after inhibitor treatment, expecting them to rapidly
gain K27me3. Surprisingly, a large proportion of generation 1
histones were refractory to K27me3 after inhibitor removal, as
compared to new generation 2 histones present in the same cells
(Figure 4A). This result was counterintuitive given that a substan-
tial fraction of generation 1 histones already carried K27me1 at
the time of inhibitor removal (Figure 3C), and we thus sought to
identify the basis for this recovery defect.
In-depth analysis of generation 1 histones revealed that
there was a strong skew toward more K36me1/2 after inhibitor
mESCs
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Figure 3. Lack of K27me3 on Parental Histones Reduces the Rate of De Novo K27me3
(A) Illustration of the question: do pre-existing K27me3 affect the kinetics of de novo K27me3 establishment?
(B) Experimental design to track de novo K27 methylation on generation 2 histones upon recovery from 7 days of EZH2 inhibitor treatment.
(C) K27 methylation levels on generation 1 histones after 7 days of EZH2 inhibitor treatment (measured at time 0 in B). Data are shown as mean ± SD, n = 3.
(D) K27 methylation dynamics on generation 2 histones with losses and gains in the absence of pre-existing K27me3 highlighted by orange and blue shaded
areas, respectively. Data are shown as mean ± SD, n = 3.
(E) The domain model predicts differences in the rate constants between untreated and recovering generation 2 histones.
See also Figure S3.treatment (Figure 4B) as well as a moderate loss of K36me3. This
is consistent with recent findings in EED knockout mESCs,
where loss of K27 methylation led to a 3-fold increase in
K36me2 and reduction of K36me3 (Oksuz et al., 2018). Similar
effects on K36me were observed upon genetic inhibition of
PRC2 by expression of H3K27M (Figures S4A and S4B),
excluding that K36 methylation changes were due to unspecific
activity of the EZH2 inhibitor. Remarkably, our setup showed that
the strong positive K36me1/2 skew was maintained throughout
the lifetime of these histones, regardless of whether the EZH2 in-
hibitor was removed (Figure 4C, generation 1).
K36me2/3 inhibited PRC2-mediated K27me2/3 in vitro
(Schmitges et al., 2011; Yuan et al., 2011), andmodeling analysis
(Figure 2F and Zheng et al., 2012) indicated that K36 methylation
directly antagonizes K27 methylation. Taken together, this
argues that K27me3 establishment on generation 1 histones is
impaired because aberrant K36me2 inhibits PRC2 activity in
cis. To further substantiate this hypothesis, we determined
K36me2 occupancy across the genome by quantitative chro-
matin immunoprecipitation sequencing (ChIP-seq) analysis.
Consistent with previous work (Streubel et al., 2018), K36me2
is a widespread mark in mESCs found in intergenic regions
and across gene bodies (Figures 4D and S4F) and overlapping
with all K27 methylation states (me1/2/3) (Figure S4G). Upon
EZH2 inhibition, K36me2 levels increased genome wide,
including genic and intergenic regions (Figures 4E and S4F).
The increase in K36me2 was most prominent in K27me3
domains, in particular, those normally low in K36me2 (Fig-ure S4H) as compared to regions marked by K27me1/2 (Figures
4F and 4G). Collectively, these results explain why K27me3 is
impaired on generation 1 histones and reveals a surprising
tardiness in reshaping the methylation landscape once estab-
lished. Pre-existing K36 methylation makes cells refractory to
change, allowing full recovery of K27me3 levels only after dilution
of these pre-existing histones over 5 rounds of cell division.
This underscores the importance of establishing correct histone
modification patterns on new histones, as an unwarranted K36/
K27 skew can affect cells across several cell divisions. Indeed,
histones incorporated after removal of the inhibitor (generations
2 and 3) also showed reminiscence of the inhibitor-induced K36
methylation skew (Figures 4C and S4C–S4E). This is partly
explained by the 10-fold elevated rate of K36 mono-methylation
of K27me2K36me0 peptides (Figure 3E). Aberrant K36me2 on
parental histones thus impacted subsequent generations of
histones that did not experience the inhibitor treatment, further
underscoring that acquisition of modifications on new histones
is influenced by the environment where they land.
DISCUSSION
Understanding how histone-based information is propagated
across cell division remains a major challenge in biology. Here
we take a quantitative modeling-based approach to tackle this
question. By measuring K27 and K36 methylation dynamics on
distinct histones, we developed a computational model that is
reusable and provides a new analysis framework to understandCell Reports 30, 1223–1234, January 28, 2020 1229
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Figure 4. K36 Methylation Locks Polycomb Domains in an
Aberrant Modification State
(A) K27me3 levels on generation 1 and generation 2 histones during
recovery from EZH2 inhibitor treatment as described in Figure 3B.
Data are shown as mean ± SD, n = 3.
(B) K36 methylation levels on generation 1 histones after 7 days of
EZH2 inhibitor treatment (time 0 in Figure 3B). Data are shown as
mean ± SD, n = 3.
(C) Heatmaps of K27 and K36methylation levels on generation 1, 2,
and 3 histones during recovery from inhibitor treatment described
in Figure 3B.
(D) Screenshot of H3K36me2 ChIP-seq signal in DMSO- (dark blue)
or EZH2i- (light blue) treated samples and H3K27me3 ChIP-seq
signal in DMSO-treated samples (green). Quantitated with refer-
ence-adjusted reads per million (RRPM), log2(n + 1) over the region
depicted. Bottom panel, EZH2 ChIP-seq signal (gray) from Marks
et al. (2012) quantitated with reads per million (RPM) over the region
depicted. Red and blue blocks represent genes in the forward or
reverse strand, respectively. Green boxes indicate H3K27me3
peaks in untreated conditions. EZH2 peaks are depicted in gray
and CpG islands in black.
(E) Left, boxplot of H3K36me2 andH3K27me3ChIP-seq signal over
1 kb windows across the genome in DMSO- and EZH2i-treated
samples. Black line, median; dashed lines, 1.5 3 interquartile
range. Quantitated with RRPM, log2(n + 1).
(F) Boxplot of H3K36me2 ChIP-seq signal over 1 kb windows
across H3K27me1, H3K27me2, and H3K27me3 domains. Black
line, median; dashed lines, 1.5 3 interquartile range. Quantitated
with RRPM, log2(n + 1).
(G) Boxplot of log2 fold change of H3K36me2 signal in EZH2i-
treated samples as compared to DMSO-treated samples in
H3K27me1, H3K27me2, and H3K27me3 domains.
See also Figure S4.
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propagation of histone modifications. Our data-driven model
selection rejects global K27 and K36 demethylation, provides
in vivo rate constants for individual reactions, and argues for
the existence of distinct methylation domains. By studying re-
covery from EZH2 inhibition, we found that pre-existing
K27me3 on old histones stimulated the rate of de novo
K27me3 establishment. Our model also revealed a detailed,
quantitative picture of the mutual antagonism between K27
and K36 methylation states. Consistent with this, inhibition of
EZH2 reshapes the K36me landscape, which in turn stabilizes
the aberrant state and impedes restoration of K27me3 upon in-
hibitor removal.
Our modeling approach was inspired by the model of Zheng
et al. (2012). Indeed, the global model (Figure 2A) has the same
model structure as presented in Zheng et al. (2012), although
we omitted 22 individual demethylation rates in favor of three
demethylation rates for K27 and three for K36 to avoid overfit-
ting. However, amodel with demethylation cannot explain stable
K27me3 states during inhibitor treatment: if K27me2 sites are
no longer methylated, demethylation should lead to a clear
decrease of K27me3 over time. We thus introduce a domain
model (Figure 2B) that is able to explain our data and is consis-
tent with no global demethylation (Reveron-Gomez et al.,
2018). Our domain model argues for the existence of distinct
populations of histones that progress toward specific states.
This is consistent with well-established principles of chromatin
organization where specific post-translational modifications
occupy distinct genomic locations (CpG islands, gene bodies,
promoter regions) and even form discrete 3D structures in the
cell nucleus (Polycomb bodies). Thus, histones are not equal in
their methylation potential, but their site of incorporation is deci-
sive for the methylation state they will acquire. Similar to Zheng
et al. (2012), we found antagonismbetween K27 andK36methyl-
ation. While Zheng et al. (2012) argue that this antagonism
manifests in decreasing K36 methylation rate constants with
increasing K27 methylations (and vice versa), we believe that a
direct comparison of K27 andK36methylation fluxes for a partic-
ular state is more appropriate. Indeed, once either K27 or K36 is
set on an otherwise balanced histone, the addition of more
methylation marks of the same kind is often more likely for
high-flux states (Figure 2F). Such a ‘‘the rich get richer’’ analogy
seems to be particularly relevant for understating the recovery
from inhibition. There, histones that have traversed to a high
K36 methylation state upon K27 inhibition are no longer able to
regain untreated K27 levels, probably because they are stuck
in a particular domain. Similar to other models that describe
epigenetic modifications in a quantitative manner (Berry et al.,
2017; Blasi et al., 2016), we also assumed mass action kinetics
for transitions between chromatin states. In contrast to other
approaches, however, we explicitly fit combinatorial histone
dynamics in a variety of experimental settings. This allowed us
to infer structure and kinetics in an unprecedented manner.
The intriguing read-write function of the enzymes that catalyze
key repressive histone modifications like K27me3 and H3K9me3
argues that chromatin states are maintained across cell division
through self-propagation (Reinberg and Vales, 2018). For PRC2,
this read-write mechanism involves the recognition of K27me3
by an aromatic cage in the EED subunit, which in turn leads toallosteric activation of EZH2 (Reinberg and Vales, 2018). Struc-
tural data support that the read-write mechanism operates
between neighboring nucleosomes (Poepsel et al., 2018), which
is relevant after replication, where nucleosomes are assembled
from either modified parental histone H3-H4 tetramers or new
unmodified H3-H4 (Xu et al., 2010). However, the biological
significance of the read-write mechanism remains a matter of
debate. Self-propagation alone is not sufficient for K27me3
maintenance in Drosophila, as a genetic contribution from poly-
comb response elements (PREs) is also required (Coleman and
Struhl, 2017; Laprell et al., 2017). Establishment of the K27me3
landscape in mESCs can also occur in the absence of pre-exist-
ing K27me3 (Højfeldt et al., 2018; Oksuz et al., 2018) and in EED
allosteric activation mutants (Oksuz et al., 2018). However, EED
allosteric activation mutants are delayed in K27 methylation and
fail to re-establish wild-type levels of K27me3 (Oksuz et al.,
2018), arguing for the importance of the read-write mechanism
in K27me3 maintenance. However, PRC2 also methylates its
binding partner JARID2 on a K27 mimicking peptide that can
activate the enzyme allosterically (Sanulli et al., 2015), and this
might contribute to reduced activity of the EED mutants. By
measuring methylation on new histones specifically, we showed
that the lack of pre-existing K27me3 reduced the efficiency of de
novo K27me3 establishment. Using mathematical modeling, we
can assign this in part to a reduced rate of K27 methylation. This
demonstrates that pre-existing H3K27me3 stimulates de novo
K27 methylation during DNA replication and argues that self-
propagation through a read-write mechanism is important for
timely restoration of K27me3 domains.
Our model shows a complex pattern of mutual antagonism
between methylation on K27 and K36. This corroborates and
extends a number of other in vivo and in vitro studies. In vitro,
the presence of K36me2/3 reduces the activity of EZH2 medi-
ated methylation in cis, while there are no reports that
K27me2/3 directly impair the activity of K36me2/3 methyltrans-
ferases (Jani et al., 2019; Schmitges et al., 2011; Voigt et al.,
2012; Yuan et al., 2011). Inhibition of K36 methylation, by
expressing the H3K36M oncohistone in cancer cells or upon
NSD1 deletion in ESCs, leads to aberrant gain and spreading
of K27me3 (Lu et al., 2016; Streubel et al., 2018). Likewise,
expression of the K27M oncohistone leads to increased levels
of K36me2 and its aberrant spreading into K27me3 domains
(Stafford et al., 2018; this paper). Our modeling shows a two-
way antagonism that is more complex and broadly involves
K27 and K36 methylation stages. However, there is currently
no evidence to support a direct effect of K27 methylation on
K36 methyltransferases, leading us to suggest that this antago-
nism reflects chromatin compaction or reduced affinity of the
K36 methyltransferases in a K27me context. Consistent with
this view, we found a remarkable increase in the rate of K36
mono-methylation on K27me2K36me0 (on new histones) when
K27me2/3 was erased from pre-existing histones. Quantitative
ChIP-seq analysis confirmed increased K36me2 upon EZH2
inhibition, but the effect was less dramatic than indicated by
mass spectrometry analysis. Given that most nucleosomes
show asymmetric K27me3 (Voigt et al., 2012), part of the
K36me2 gain might reflect an increase in symmetric K36me
that would be masked in ChIP-seq experiments. In cells,Cell Reports 30, 1223–1234, January 28, 2020 1231
K27me3 and K36me3 domains do not generally overlap, but
there is a substantial overlap of the K36me2 signal with
K27me2 occupancy as well as some overlap with K27me3
domains (this paper; Streubel et al., 2018). It was suggested
that these modifications might occur on different nucleosomes.
However, mass spectrometry analysis shows substantial co-
occurrence of these marks on the same histone tail (K36me2-
3K27me1/2/3: 11.6%) (this paper; Jung et al., 2010; Zheng
et al., 2012), arguing that they are not mutually exclusive. Our
modeling and kinetics analysis indicate that K27me is imposed
first, followed by methylation of K36, as speculated previously
(Schmitges et al., 2011). This explains how histone H3 can
acquire both marks despite K36me directly impairing PRC2
activity. If K36me is allowed to establish first (as in the context
of EZH2 inhibition), this in turn impairs K27me2/3 establishment
on those nucleosomes.
We propose that one biological implication of the K27/K36
methylation antagonism is to enhance stability of epigenetic
states. Methylation on these sites, in particular K36me2 and
K27me3 (Streubel et al., 2018 and this paper), are keeping each
other incheckby restrainingunwarrantedspreading.Weobserved
that, upon recovery fromEZH2 inhibition, pre-existing histonesdid
not acquire K27me3 and retained an aberrant high level of
K36me2. The epigenetic state of old histones is thus locked, in
this case, in an aberrant state, and changing this state during
recovery relies on dilution by new naive histones during replication
in order to reset the K27/K36methylation balance. This resistance
tochange is further enhancedby the lackof EZH2allosteric activa-
tion in early recovery (see above) and, intriguingly, a slight skew to-
ward K36me for several histone generations. The prediction from
these observations (and the fact that almost all histone tails carry
some level of K27/K36 methylation) is that the K27/K36 methyl-
ation antagonism stabilizes epigenetic states and provides a bar-
rier to changes in cell identity that can be overridden globally by
cell proliferation. Recently, profiling histonemodifications in tumor
samples has revealed pervasive K27me3 loss and K36me2 gain
across different cancers (Noberini et al., 2019). We provide evi-
dence that an increased rate of cell division alone might lead to
the loss of K27me3 by dilution (this paper; Alabert et al., 2015). In
addition to mutations in histones and chromatin regulators that
directly affect K27/K36 methylation balance, a more general
reduction in K27me3might thus be driven by changes in prolifera-
tion ratesduringcellular transformation.This is relevant toconsider
in the context of targeted therapeutic intervention aimed at reset-
ting the epigenetic landscape.STAR+METHODS
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Anja
Groth (anja.groth@bric.ku.dk).
This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
E14 mESCs cell culture
E14 mESCs (male) were cultured at 37C and 5% Co2 on gelatin-coated plates in 2i/LIF medium (2i custom made medium (Thermo
Fisher)) supplemented with Pen-Strep (GIBCO), 2mM Glutamax (GIBCO), 50 mM bmercaptoethanol (GIBCO), 0.1mM nonessential
amino acids (GIBCO), 1mM sodium pyruvate (GIBCO), N2+B27 (Thermo Fisher), GSK3i (CHIR99021), MEKi (PD0325901), Leukemia
Inhibitor Factor (LIF; produced in Kristian Helin laboratory). Medium was supplemented with light, medium or heavy arginine and
lysine (R0 Arginine hydrochloride (Sigma A6969), R6 Arginine 13C6 (CNLM-2265-H1), R10 Arginine 13C6 15N4 (CNLM- 539-H1),
K0 Lysine hydrochloride (Sigma L8662), K4 Lysine 4,4,5,5- d4 (DLM-2640-1 1gram), K8 Lysine 13C6 15N2 (CNLM-291-H-1
1gram) Cambridge isotope). We passaged cells every 2-3 days by removing the medium, washing cells in PBS, dissociating cells
with 0.25% trypsin EDTA (GIBCO) with gentle disruption of colonies by pipetting, resuspending cells in medium, pelleting by centri-
fugation and resuspending cells and plating at density of 5x106 cells/15cm dish.
Drosophila S2 Cell Culture
S2 cells (male) were grown in suspension in spinners in M3+BPYE media: Shields and Sang M3 Insect Medium (Sigma, S-8398),
KHCO3 (Sigma, 12602), yeast extract (Sigma, Y-1000), bactopeptone (BD, 211705), 10% heat-inactivated FCS (GE Hyclone,
SV30160.03) and 1X penicillin/streptomycin (GIBCO, 151400122). Cells were incubated at 25C with 5% CO2.
TIG3 K27M and TIG3K9M cell lines generation
Stable TIG3 cell lines expressing H3.3K27M or H3.3K9M were generated by lentiviral transduction. Briefly, lentiviral particles were
produced by transfection of 293 FT cells with viral packaging (Pax8) and envelope (VSV) plasmids along with the appropriate vector
containing the cDNA of interest (pCDH-EFI-MCS-IRES-PURO-H3.3K27M or pCDH-EFI-MCS-IRES-PURO-H3.3K9M). Virus-con-
taining media was harvested after 48h and 1ml was used to infect TIG3 cells. Transduced cells were allowed to recover for 24h
and then cultured under selection (1 mg/mL Puromycin). Cells were harvested 8 days post transduction for immunoblot analysis.
PCDH-EFI-MCS-IRES-PURO-H3.3K27M and pCDH-EFI-MCS-IRES-PURO-H3.3K9M plasmids were kindly provided by David Allis
laboratory (The Rockefeller University, New York) and sequence verified.
TIG3 K27M and TIG3K9M cell culture
TIG3 cells were grown in DMEM containing 10% FBS, 1% penicillin/streptomycin and 1 mg/mL Puromycin. Medium was supple-
mented with MEM non-essential amino acid mix.
METHOD DETAILS
EZH2 inhibition and wash out
E14 mESCs were treated with 10 mM of EPZ6438 EZH2 inhibitor (MedChem Express) for indicated time. For washout, cells were
washed three times in PBS, trypsinized, washed in growth medium, and plated into R6K4 fresh medium.
Sample preparation for histone modification analysis by MS
Acid extracted histones were resuspended in La¨mmli buffer and separated by a 14%–20% gradient SDS-PAGE, stained with Coo-
massie (Brilliant blue G-250). Protein bands in the molecular weight range of histones (15-23 kDa) were excised as single band/frac-
tion. Gel slices were destained in 50% acetonitrile/50mM ammonium bicarbonate. Lysine residues were chemically modified by
propionylation for 30min at RT with 2.5% propionic anhydride (Sigma) in ammonium bicarbonate, pH 7.5 to prevent tryptic cleavage.
This step added a propionyl group only to unmodified andmonomethylated lysines,whereas lysineswith other side chainmodification
will not obtain an additional propionyl-group. Subsequently, proteins were digested with 200ng of trypsin (Promega) in 50mM ammo-
niumbicarbonate overnight and the supernatant was desalted byC18-Stagetips (reversed-phase resin) and carbon Top-Tips (Glygen)
according to the manufacturer’s instructions. Following carbon stage tip, the dried peptides were resuspended in 17 mL of 0.1% TFA.
LC-MS analysis of histone modifications
5 mL of each sample were separated on a C18 home-made column (C18RP Reposil-Pur AQ, 120 3 0.075mm x 2.4 mm, 100A˚, Dr.
Maisch, Germany) with a gradient from 5% B to 30% B (solvent A 0.1% FA in water, solvent B 80% ACN, 0.1% FA in water) over
32min at a flow rate of 300nl/min (Ultimate 3000 RSLC Thermo-Fisher, San Jose, CA) and directly sprayed into a Q-Exactive HF
mass spectrometer (Thermo-Fisher Scientific). The mass spectrometer was operated in the PRM mode to identify and quantifye2 Cell Reports 30, 1223–1234.e1–e8, January 28, 2020
specific fragment ions of N-terminal peptides of human histone 3.1 and histone 4 proteins. In this mode, themass spectrometer auto-
matically switched between one survey scan and 9MS/MS acquisitions of them/z values described in the inclusion list containing the
precursor ions, modifications and fragmentation conditions (Table S1). Survey full scan MS spectra (from m/z 250–800) were
acquired with resolution 30,000 atm/z 400 (AGC target of 3x106). PRM spectra were acquired with resolution 15,000 to a target value
of 2x105, maximum IT 60ms, isolation 2 window 0.7 m/z and fragmented at 27% normalized collision energy. Typical mass spectro-
metric conditions were: spray voltage, 1.5kV; no sheath and auxiliary gas flow; heated capillary temperature, 250C.
Quantification of histone modifications
Data analysis was performed with Skyline (version 3.6) (MacLean et al., 2010) by using doubly and triply charged peptide masses for
extracted ion chromatograms (XICs). Peaks were selected manually and the integrated peak values (Total Area MS1) were exported
as. csv file for further calculations. The percentage of eachmodification within the same peptide is derived from the ratio of this struc-
tural modified peptide to the sum of all isotopically similar peptides. Therefore, the Total Area MS1 value was used to calculate the
relative abundance of an observed modified peptide as percentage of the overall peptide. The unmodified peptide of histone 3.1 (aa
41–49) was used as indicator for total histone 3.1. Coeluting isobaric modifications were quantified using three unique MS2 fragment
ions. Averaged integrals of these ions were used to calculate their respective contribution to the isobaric MS1 peak (e.g., H3K36me3
and H3K27me2K36me1). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via
the PRIDE partner repository with the dataset identifier PXD014807.
ChIP-seq
Cells were grown for 7 days in 2i/LIF media supplemented with 10 mM EZH2i (EPZ6438) or equivalent volume of DMSO. Cells were
then processed using the truChIP Chromatin Shearing Kit (Covaris, 520127). In brief, cells were washed and fixed in 1% formalde-
hyde for 5 minutes. Crosslinking was quenched by adding Covaris quenching buffer and the reaction was incubated for 5 minutes.
Fixed cells were washed twice in 1X PBS, scraped off in 1X PBS and spun down. Cell pellets were snap-frozen in liquid nitrogen, and
stored at 80C until lysis. Nuclei isolation was performed on fixed cells following manufacturer’s instructions. 20 million cells were
sonicated in 1mL tubes using a Covaris M220 with the following settings: duty cycle 10% intensity, 200 cycles/ burst, 20 minutes
processing time, 7C bath temperature, water level full. Sonicated chromatin was centrifuged at 14,000 rpm at 4C for 10 minutes
and the supernatant was isolated for subsequent steps. In parallel, Drosophila S2 cells were fixed, lysed and sonicated as described
above. For quantitative ChIP analysis of H3K36me2 andH3K27me3 input chromatin wasmixedwithDrosophilaS2 chromatin (0.05%
of total chromatin) after sonication. 30 mg of mESCs sonicated chromatin or 30 mg total of mixedmESCs andDrosophila S2 sonicated
chromatin were diluted up to 500 mL with dialysis buffer (4% glycerol, 10mM Tris-HCl, 1mM EDTA, 0.5mMEGTA; pH 8) and 400 mL of
incubation buffer (2.5% Triton X-100, 0.25% sodium deoxycholate, 0.25% SDS, 0.35M NaCl, 10mM Tris-HCl; pH 8) supplemented
with leupeptin, aprotinin, pepstatin, and PMSF. Chromatin was pre-cleared with either Protein G agarose beads pre-coupled with
bridging antibody (Active Motif #53017) following manufacturer’s instruction (pG-Ab) or Protein A agarose beads for 1 hour at
4C. After pre- clearing, chromatin was incubated overnight at 4C with 10 mg of the appropriate antibody (H3K27me1: Active Motif
mAb #61015; H3K27me2: Cell Signaling mAb #9728; H3K27me3: Cell Signaling mAb #9733; H3K36me2: AbCam mAb #176921),
followed by incubation for 3 hours with either pre-blocked Protein G-Ab or Protein A agarose beads (incubated in 1 mg/ml BSA in
RIPA buffer overnight). Chromatin bound to beads was washed three times in RIPA buffer (140 mM NaCl, 10mM Tris-HCl, 1mM
EDTA, 1% Triton X-100, 0.1% SDS, 0.1% sodium deoxycholate, 1mM PMSF; pH 8), four times in RIPA buffer with 0.5 M NaCl,
once in LiCl buffer 3 (250mM LiCl, 10mM Tris-HCl, 1mM EDTA, 0.5% NP-40, 0.5% sodium deoxycholate; pH 8) and twice in TE
(10mM Tris-HCl, 1mM EDTA; pH 8). Chromatin was incubated with 125 mg/ml RNase A for 30 minutes at 37C SDS was then added
to a final concentration of 1% and samples were incubated with 250 mg/ml proteinase K for 10 hours at 37C followed by 6 hours
incubation at 65C for de-crosslinking. De-crosslinked DNAwas purified and size selected with Agencourt AMPure XP beads (Beck-
manCoulter, A63881) by using first a 0.55:1 ratio followed by a 3:1 final ratio to obtain fragments between 200-700 bp. Finally, 10ng of
purified DNAwas subjected to end repair, A-tailing and amplification using the KAPAHyperprep kit protocol (Roche, KK8504). Before
and after amplification (7 PCR cycles) DNA was cleaned-up with Agencourt AMPure XP beads at a 0.8:1 ratio.
Data sequencing, processing and analyses
ChIP-seq libraries were sequenced 75 bp single-end on an Illumina NextSeq 500. Trim Galore was used to trim adaptor sequences.
Reads weremapped to themm10 assembly mouse genome using Bowtie2 (Langmead and Salzberg, 2012). Reads with MAPQ < 20,
PCR duplicates, and reads that overlapped with the Broad Institute sequencing blacklist (ENCODE Project Consortium, 2012) were
filtered out. For downstream analyses, remaining reads were extended by 250bp. Reads were mapped to the dm3 assembly
Drosophila genome using Bowtie2 (Langmead and Salzberg, 2012) to calculate reference-adjusted reads per million (RRPM) normal-
ization factors. The number of uniquely mapped reads after deduplication was used to calculate RRPM as in (Reveron-Gomez et al.,
2018). Fold change was calculated as the division of RRPM normalized signal of EZH2i treated samples by the RRPM normalized
signal of DMSO treated samples and log transformed. Bedgraphs for screenshots and scatterplots were generated and visualized
using Seqmonk (version 1.42.1). Boxplots were generated in R using custom scripts.Cell Reports 30, 1223–1234.e1–e8, January 28, 2020 e3
Peak calling
Peak calls were created with SICER (Zang et al., 2009) using redundancy threshold = 1, window size = 500, fragment size = 250,
effective genome fraction = 0.79, gap size = 1500 and an FDR threshold of 0.01. Input samples were used in peak calling to assess
background and to determine true signal from IP enrichment.
Mathematical modeling of histone tail methylation
The dynamics of combinatorial histonemodifications of H3K27 and H3K36 have beenmodeled previously with systems of ordinary dif-
ferential equations based on the assumption of mass action kinetics (Zheng et al., 2012). Here, we also employ ordinary differential
equationmodels based onmassaction kinetics anddescribe the observedmodifications,which are averagedover all cells and histones
of the individual generations (Figure 1A). We first describe the global model which includes demethylation, and then propose a different
model that accounts for domains of specificmodifications and that is able to explain data obtained in an inhibitor experiment (Figure 2D).
Global model
The first model we considered consists of 45 state variables, with 15 state variables for each of the three generations (all possible
combinations except K27me3K36me3) (Figure 2A). It describes the change in modifications due to methylation and demethylation
as well as dilution, which occurs when the cells divide and new, unmodified histones are incorporated. Thismodel is similar to the one
proposed by (Zheng et al., 2012). To obtain a model for the relative abundance of modifications, we first derived the model for the
absolute number of histone modifications. The ODE system for the absolute number of histone modifications ~xg = ð~xg;00;.; ~xg;23Þ
reads for generation g = 1;2;3
~xg;ij = cfði;jÞ= ð0;0Þgði; jÞcgðtÞN
+cfi > 0^ði;jÞsð3;3Þgði; jÞki1j/ij~xg;i1j
+cfj > 0^ði;jÞsð3;3Þgði; jÞkij1/ij~xg;ij1
 cfi < 3^ði;jÞsð2;3Þgði; jÞKij/i + 1j~xg;ij
 cfi < 3^ði;jÞsð3;2Þgði; jÞKij/ij + 1j~xg;ij
+cfi < 3^ði;jÞsð2;3Þgði; jÞdK27;i + 1~xg;i + 1j
+cfj < 3^ði;jÞsð3;2Þgði; jÞdK36;j + 1~xg;ij + 1
 cfi > 0^ði;jÞsð3;3Þgði; jÞdK27;i~xg;ij
 cfj > 0^ði;jÞsð3;3Þgði; jÞdK36;j~xg;ij
_N = cN:
(1)
The indicator function is denoted by c, kij/i +1j is the rate constant for K27 methylation, kij/ij + 1 is the rate constant for K36 methyl-
ation, i denotes the number of methyl groups at K27, j the number of methyl groups at K36, NðtÞ=N0 ecðtt0Þ the total number of
histone tails with Nðt0Þ=N0 being the number of histone tails at the beginning of the experiment and c being the cell division rate.
Furthermore, dK27;i is the rate constant for demethylation, i.e., reducing the number of methyl groups at K27 from i to i 1. The special
cases with ði; jÞsð2; 3Þ and ði; jÞsð3;2Þ arise because we did not observe any K27me3K36me3methylations. Wemodel explicitly the
three different generations of histones (Figure 1A). Newly incorporated histones are unmodified and belong to the generation of the
corresponding culture medium (Figure 1A):
cgðtÞ =
8<
:
cft <3hgðtÞc g= 1:
cf3h%t < 0hgðtÞc g= 2:
cftR0hgðtÞc g= 3:
ci:j: (2)
The cell division rate c is multiplied with the number of histone tails in Equation 1, because the number of histone tails is proportional
to the number of cells and thus duplicated at cell division. When changing the culture medium, initially no histones of this generation
are present:
~xg;ij tð Þ= 0 for
8<
:
t < t0 g= 1;
t <  3h g= 2;
t < 0h g= 3;
ci; j: (3)
The model comprises nj = 29 parameters
j= ðc;dK27;1;dK27;2;dK27;3;dK36;1;dK36;2;dK36;3; k00/01; k00/10; k01/02; k01/11; k02/03; k02/12;k03/13; k10/11; k10/20; k11/12; k11/21; k12/13; k12/22; k13/23; k20/21; k20/30; k21/22; k21/31;k22/23; k22/32; k30/31; k31/32Þe4 Cell Reports 30, 1223–1234.e1–e8, January 28, 2020
which are required for the simulation of the observable. However, the relative weights are not independent and, thus, the model
comprises only 28 independent parameters. To bring the system to relative scale, we divide the total abundance of modifications
by the number of histone tails
xg;ij =
~xg;ij
N_xg;ij =
_~xg;ij
N
 ~xg;ij
_N
N2
:
This yields for the relative scale
_~xg;ij =cfði;jÞ= ð0;0Þgði; jÞcgðtÞ  cgðtÞ
~xg;ij
N
+cfi > 0^ði;jÞsð3;3Þgði; jÞki1j/ij
~xg;i1j
N
+cfj > 0^ði;jÞsð3;3Þgði; jÞkij1/ij
~xg;ij1
N
 cfi < 3^ði;jÞsð2;3Þgði; jÞkij/i + 1j
~xg;ij
N
 cfj < 3^ði;jÞsð3;2Þgði; jÞkij/ij +1
~xg;ij
N
+ cfi < 3^ði;jÞsð2;3Þgði; jÞdK27;i + 1
~xg;i + 1j
N
+ cfj < 3^ði;jÞsð3;2Þgði; jÞdK36;j + 1
~xg;i j +1
N
 cfi >0^ði;jÞsð3;3Þgði; jÞdK27;i
~xg;ij
N
cfj > 0^ði;jÞsð3;3Þgði; jÞdK36; j
~xg;ij
N=c i;jð Þ= 0;0ð Þf g i; jð Þcg tð Þ  cg tð Þxg;ij +c i > 0^ i;jð Þs 3;3ð Þf g i; jð Þki1j/ijxg;i1j
+c j > 0^ i;jð Þs 3;3ð Þf g i; jð Þkij1/ijxg;ij1  c i < 3^ i;jð Þs 2;3ð Þf g i; jð Þkij/i + 1jxg;ij
c j < 3^ i;jð Þs 3;2ð Þf g i; jð Þkij/ij + 1xg;ij + c i <3^ i;jð Þs 2;3ð Þf g i; jð ÞdK27;i +1xg;i + 1j
+c j < 3^ i;jð Þs 3;2ð Þf g i; jð ÞdK36;j + 1xg;ij +1  c i > 0^ i;jð Þs 3;3ð Þf g i; jð ÞdK27;ixg;ij
c j > 0^ i;jð Þs 3;3ð Þf g i; jð ÞdK36;jxg;ij
for g= 1;2;3 and i; j = 0;1;2; 3. At relative scale, Equation 2 can be seen as the dilution that occurs due to cell division. The
observables, i.e., the measurable output of the model, are the methylation ratios obtained by
yg;ij =
xg;ijP
i;jxg;ij
:
We assumed that methylation rates do not change for different culture media and different dynamics were obtained solely due to
presence/absence of dilution (Equation 2) and different initial conditions (Equation 3).
Domain model
As an alternative, we considered that demethylation of K27 and K36 does not exist. For this, we proposed a model which assumes
that certain domains of the chromatin are determined to acquire certain methylation patterns, e.g., due to particular transcription
factor binding or parental histone context. For example, histones of domain 00 do not get any methylations at all; histones of the
domain 20 will get no additional methylations once the 20 state is reached; histones of the domain 31 can acquire the 31 methylation
via different pathways (Figure 2B). The histone composition tends towards the state where all domains acquired their determined
state. Since newly incorporated histones are unmodified ð00Þ, the model still shows dynamics. To construct this domain model,
we denoted wlm as the relative size of domain lm, with
P
l;m
wlm = 1. Let x
lm
g;ij be the relative abundance of histone tails with methylation
K27meiK36mej in domain lm for generation g. Then the ODEs are
_xlmg;ij =c i;jð Þ= 0;0ð Þf g i; jð Þcg tð Þ  cg tð Þxlmg;ij +c 0< i%lf g i; jð Þki1j/ijxlmg;i1j +c 0< j%mf g i; jð Þkij1/ijxlmg;ij1  c i < lf g i; jð Þkij/i + 1jxlmg;ij  c j <mf g i; jð Þkij/ij +1xlmg;ij
with cgðtÞ as defined in Equation 2 and initial conditions
xlmg;ij tð Þ= 0 for
8<
:
t < t0 g= 1;
t <  3h g= 2;
t < 0h g= 3;
ci; j; l;m: (4)
The observables are obtained by
yg;ij =
P
l;mwlmx
lm
g;ijP
l;mwlm
P
i;jx
lm
g;ij
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We assumed that the methylation rate constants are shared between the domains, and estimated them together with the relative
sizes of the domains from the data. The model comprises nj = 38 parameters
j= ðc; k00/01; k00/10; k01/02; k01/11; k02/03; k02/12; k03/13; k10/11; k10/20; k11/12; k11/21;k12/13; k12/22; k13/23; k20/21; k20/30; k21/22; k21/31; k22/23; k22/32; k30/31; k31/32;w00;w01;w02;w03;w10;w11;w12;w13;w20;w21;w22;w23;w30;w31;w32Þ
which are required for the simulation of the observable.
Model calibration
Experimental measurements are generally noise corrupted and the model needs to take this into account. It has been shown that
often a Laplace measurement noise model outperforms a Gaussian noise model (Maier et al., 2017). Therefore, we first compared
theGaussian and Laplace distributedmeasurement noisemodel.We compared themodel output and the observables on a log-scale
and offsetted both to cope with zero measurements
log

yg;ij + offset

 p

log

yg;ij + offset
logyg;ij + offset;s; (5)
with noise distribution p. The model parameters, including methylation rate constants, cell cycle and measurement noise, are
comprised in the parameter vector q. The measurement for the time point indexed by k is denoted by ykg;ij. The log-likelihood
assuming Gaussian noise is given by
logLðqÞ = logLDðqÞ=  1
2
X
g;i;j;k
0
B@log2 ps2 +
0
B@ log

y
k
g;ij
+offset

 logyg;ijðtk ; qÞ+offset
s
1
CA
21
CA (6)
and for the Laplace noise by
logLðqÞ =
X
g;i;j;k
0
B@logð2 sÞ +
logyk
g;ij
+offset

 logyg;ijðtk ; qÞ+offset

s
1
CA: (7)
Since we did not have prior information as our predicted domains do not correspond to steady state measurements and cannot be
observed in a population of cycling cells, we used a maximum likelihood approach. The optimal parameters are obtained by maxi-
mizing the likelihood function, yielding the maximum likelihood estimate (MLE) bq. Maximum likelhood estimation was performed us-
ing the parameter estimation toolbox PESTO (Stapor et al., 2018), which provides an interface to the MATLAB function fmincon. For
numerical reasons, we transformed parameters which are supposed to be positive to a logarithmic scale (Hass et al., 2019). The
models were simulated using AMICI (Fro¨hlich et al., 2017), which provides an interface to the SUNDIALS solver suite (Hindmarsh
et al., 2005). For model comparison, we employed the Bayesian Information Criterion (BIC) (Schwarz, 1978). The BIC value for model
indexed by m is
BICm =  2logL
bqm+ logðnDÞnqm; (8)
with nD data points. The BIC rewards good likelihood values and penalizes the number of parameters. We chose offset = 10
1which
provided the best fit with respect to the QQ-plots for the global model and the domain model with 15 domains using Laplace noise
(Figures S2A and S2B).We performed 100 local optimization runs for Gaussian and Laplace noise using the hierarchical approach for
optimization proposed by Loos et al. (Loos et al., 2018). For the hierarchical approach, we analytically calculated the measurement
noise parameter s, which is shared for all time points, observables and generations. The hierarchical approach outperformed the
standard approach for optimization. We found strong support for Laplace noise over Gaussian noise for both models (DBIC >
600). Both models were able to describe the data from untreated cells well (Figures 2C, S2C, and S2D). However, a model without
demethylation for K27 was not able to describe, e.g., levels of K27me3K36me0 or K27me3K36m1 (Figure S2C). Since only the
domain model is able to explain inhibitor experiments (Figure 2E), we reject the global model for the description of K27K36 dynamics.
Model reduction and averaging
We did not expect all 15 domains to be necessary to explain the data and thus the domain model could be overparametrized. Since it
was unclear which domains exist a priori, we performed model selection to detect the present domains. If we consider all potential
combinations of domains, we would end up with 215 models, which is computationally too expensive. Performing a combination ofe6 Cell Reports 30, 1223–1234.e1–e8, January 28, 2020
forward-selection and backward-elimination, we found eight domains 01;02;03; 13;21;23; 30;32 which were necessary to explain
the data. To be robust against the precise choice of domains, we performedmodel averaging over all models whichwere calibrated in
the process of model reduction. For this, the BIC weight,
us =
e
1
2
BICs
PnM
~s= 1e
1
2
BIC~s
; (9)
of each of the nM = 137 models was employed (Figure S2H). Since the rates are not comparable across models due to different
domains, we analyzed the fluxes, which are the product of the abundance of the state and the methylation rate constant
fluxij/i + 1j =
Xi + 1
l = 0
Xj
m= 0
xlm1;ij toð Þkij/i + 1j;fluxij/ij + 1 =
Xi
l = 0
Xj + 1
m= 0
xlm1;ij toð Þkij/ij + 1:
The fluxes shown in Figure 2F are model averaged using the BIC weights (Equation 9) (Wasserman, 2000).
Model prediction and validation
To further test and validate the models, we used the data of the inhibitor experiment. Using our calibrated models, we predicted the
total amount of K27me3 in generation 1 under inhibitor treatment (Figure 2D). For this, we assumed that the tri-methylation rates were
inhibited by a factor k:
k2j/3j;inh = ð1 kÞk2j/3j;untr: (10)
To obtain reasonable values for k, we analyzed a simplifiedmodel which only considers K27methylations of histones of generation 3,
x0; x1; x2; x3 for un-, mono-, di-, and tri-methylation at K27 and assumed independence between the methylation sites. The model
reads
_x0 = c cx0  k0/1x0 +dK27;1x1;_x1 =  cx1 + k0/1x0  k1/2x1 +dK27;2x2  dK27;1x1;_x2 =  cx2 + k1/2x1  k2/3x2 +dK27;3x3  dK27;2x2;_x3 =  cx3 + k2/3x2  dK27;3x3:
The steady states for K27me3 for untreated cells and cells in the inhibitory experiment are given by
x3;untr =
k2/3x2;untr
dK27;3 + c
; (11)x3;inh =
ð1 kÞk2/3x2;inh
dK27;3 + c
: (12)
Thus, K27me3 only depends on the tri-methylation rate constant k2/3, the demethylation rate constant dK27;3, the dilution rate con-
stant c, the amount of relative K27me2 and in the inhibitor case the factor k (Equation 10) by which the tri-methylation is inhibited
(Figure S2E). Thus, we obtained
dK27;3 + c
k2/3
=
x2;untr
x3;untr
= ð1 kÞ x2;inh
x3;inh
(13)0k = 1 x2;untrx3;inh
x3;untrx2;inh
: (14)
Using the last time point for generation 3 from data Dinh, we obtained for three replicates a rough estimate k= 0:928± 0:052 (Fig-
ure S2G). The same expression for k (Equation 14) is also valid for the domain model. We compared our model predictions to the
experimental data for K27me3 levels, i.e., summing all states with K27me3, to be robust against potential effects of the inhibitor
on K36 methylations. We only assumed the tri-methylation rate to change. However, if also mono-, or di-methylation changes,
the model predictions would be even lower and the illustrated predictions in Figure 2E can be seen as rough estimates for the upper
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Modeling differences between generation 2 histones in untreated and recovery experiments
For all further analyses, we used a domain model with eight domains (01,02,03,13,21,23,30,32). To detect differences between
generation 2 histones of untreated and recovering cells, we performed a forward selection to find the most substantial changes in
rate constants. In the first step of forward selection, only changes in the rate constants k00/10 and k20/30 yield substantial improve-
ments with DBIC < 10. Allowing the rate constant for k00/10 to differ yields the biggest improvement in BIC values, and this rate
constant is estimated to be roughly halved (0.47) in cells lacking K27me3. Overall, the model allowing for differences in k00/10,
k00/01, k20/21 and k20/30 has the lowest BIC and thus the highest quality (Figures 3E and 3F).
Implementation
The MATLAB code used for the analysis of the manuscript is made available via Zenodo (https://zenodo.org/record/3353481). The
toolboxes used for the ODE simulation (AMICI) and parameter estimation (PESTO) are both available under https://github.com/
ICB-DCM. The analysis was performed with MATLAB 2017b.
QUANTIFICATION AND STATISTICAL ANALYSIS
Figure 1: 6% n% 9 biological replicates have been performed. Figure 2D and 2E: 3 biological replicates have been performed. Fig-
ures 3 and 4A–4C: 3 biological replicates have been performed. Figures 4: 2 biological replicates have been performed. The mean
with standard deviation is shown.
DATA AND CODE AVAILABILITY
The mass spectrometry dataset generated during this study is available at Pride:PXD014807. The sequencing datasets generated
during this study are available at GEO:GSE135029. The MATLAB code used for the mechanistic modeling is available at Zenodo
[https://zenodo.org/record/3353481]. The publicly available EZH2 data reported in this paper is available at GEO:GSM590133.e8 Cell Reports 30, 1223–1234.e1–e8, January 28, 2020
